New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2013
10:00 EDTARMH, URBN, UPI, BP, JCI, MS, LIFE, KMI, SFLY, TRIB, RHHBY, BDX, DO, FFIV, FE, FTNT, LRE, OZM, OTEX, COHOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ARM Holdings (ARMH) downgraded to Hold from Buy at Benchmark Co.... Amgen (AMGN) downgraded to Neutral from Outperform at Credit Suisse... Becton Dickinson (BDX) downgraded to Neutral from Buy at Mizuho... Diamond Offshore (DO) downgraded to Neutral from Outperform at Credit Suisse... F5 Networks (FFIV) downgraded to Hold from Buy at Needham... FirstEnergy (FE) downgraded to Underperform from Hold at Jefferies... Fortinet (FTNT) downgraded to Market Perform from Outperform at JMP Securities... LRR Energy (LRE) downgraded to Neutral from Outperform at RW Baird... Och-Ziff Capital (OZM) downgraded to Market Perform from Outperform at Keefe Bruyette... Open Text (OTEX) downgraded to Hold from Buy at Stifel Nicolaus... Roche (RHHBY) downgraded to Neutral from Outperform at Exane BNP Paribas... Trinity Biotech (TRIB) downgraded to Neutral from Buy at Roth Capital... Urban Outfitters (URBN) downgraded to Neutral from Overweight at Atlantic Equities... Uroplasty (UPI) downgraded to Market Perform from Outperform at JMP Securities... BP (BP) downgraded to Sector Perform from Outperform at RBC Capital... Johnson Controls (JCI) downgraded to Neutral from Buy at Lazard Capital... Morgan Stanley (MS)downgraded to Neutral from Positive at Susquehanna... Life Technologies (LIFE) downgraded to Market Perform from Outperform at William Blair... Kinder Morgan (KMI) downgraded to Hold from Accumulate at Tudor Pickering... Shutterfly (SFLY) downgraded to Neutral from Buy at Monness Crespi... Coach (COH) downgraded to Outperform from Buy at CLSA.
News For ARMH;BDX;DO;FFIV;FE;FTNT;LRE;OZM;OTEX;RHHBY;TRIB;URBN;UPI;BP;JCI;MS;LIFE;KMI;SFLY;COH From The Last 14 Days
Check below for free stories on ARMH;BDX;DO;FFIV;FE;FTNT;LRE;OZM;OTEX;RHHBY;TRIB;URBN;UPI;BP;JCI;MS;LIFE;KMI;SFLY;COH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
July 16, 2014
15:02 EDTMSMorgan Stanley July 32.5 straddle priced for 3.3% move into Q2
Subscribe for More Information
14:57 EDTMSEarnings Preview: Morgan Stanley to report amid optimism on Wealth Management
Morgan Stanley (MS) is scheduled to report second quarter earnings before the open on Thursday, July 17 with a conference call scheduled for 10:00 am ET. Morgan Stanley is a bank holding company. EXPECTATIONS: Analysts are looking for EPS of 55c on revenue of $8.2B, according to First Call. The consensus range for EPS is 52c-64c on revenue of $7.58B-$8.65B. Morgan Stanley (MS) reported stronger than expected first quarter results, as the company's revenue rose to $8.9B from $8.2B. The company's wealth management unit generated pre-tax income of $691M, versus $597M in the same period a year earlier. Morgan Stanley's investment management unit saw its pre-tax income from continuing operations rise to $263M from $187M, while the pre-tax income of its institutional Securities division rose $1.4B, up from $799M. Morgan Stanley's wealth management business will continue growing and the business' return on equity will eventually be well over 10%, said the company's CEO, Tom Gorman last month, according to The New York Times. But declines in the bank's fixed income revenues may make it harder for its securities businesses to exceed a 10% return on equity, and the firm has significantly reduced its trading operations, the newspaper quoted the CEO as saying. PEERS: On July 15, Goldman Sachs reported stronger than expected results, as the bank's investment banking unit saw its net revenue rise 15% year-over-year, while the net revenues generated by its Institutional Client Services unit dropped 11%. But Goldman's investing and lending unit saw its net revenues surge 46% year-over-year. Citigroup (C), on July 14, reported higher than expected Q2 EPS excluding certain items but lower than expected revenue. Revenue from Citi's Institutional Client Group dropped 11%, as revenue from fixed income and equity markets fell. STREET RESEARCH: On July 10, research firm Bernstein recommended Morgan Stanley's stock due to its exposure to high margin investment banking. Bernstein also liked Morgan Stanley because of its exposure to wealth management. PRICE ACTION: Morgan Stanley is up almost 9% over the last three months and it has surged over 23% in the last twelve months.
13:18 EDTBPBP aims to invest $10B in Egypt gas project, Daily News Egypt says
Subscribe for More Information
13:06 EDTFTNTIT security stocks advance after upbeat Goldman note
Shares of a number of IT security stocks are rallying after Goldman Sachs wrote that it was upbeat on the sector in a note to investors today. WHAT'S NEW: Goldman Sachs analyst Matthew Niknam assumed coverage of the Security Software sector with an Attractive rating. Cyber threats have become larger and more costly, so many companies are increasing the amount of money they spend on IT security, Niknam wrote. Spending on security is increasing by the highest rate since 2010, the analyst estimated. Companies in the sector should see their free cash flow growth accelerate, while cash rich tech companies could become interested in carrying out M&A transactions with security vendors, the analyst predicted. Additionally, more mature companies in the sector should be able to buy back more of their shares going forward, Niknam believes. He identified Palo Alto (PANW) as his top pick in the space, as he believes that the company provides "the most unique blend of disruptive long-term growth and accelerating profitability." The company is poised to gain additional market share, while its growth going forward should beat expectations, Niknam stated. He raised his price target on the shares to $97 from $91 and kept a Conviction List-Buy rating on the stock. Meanwhile, the analyst upgraded another stock in the sector, FireEye (FEYE), to Buy from Neutral after assuming coverage of the shares. The company's status as the market leader in fighting Advanced Persistent Threats, or APTs, leaves it well-positioned in the current market, he contended. An IT survey indicates that most respondents plan to increase their APT-related spending, and 59% of the respondents say they plan to spend more money on solutions from a new vendor, Niknam reported. Furthermore, FireEye's revenue growth likely accelerated in Q2 and its revenue should beat expectations in 2014 and 2015, while the company's free cash flow should come in above consensus levels next year, Niknam predicted. FireEye may eventually be acquired by another company, according to Niknam, who raised his price target on the shares to $42 from $36. WHAT'S NOTABLE: Niknam initiated coverage of Proofpoint (PFPT) with a Buy rating as he predicted that the company's growth and free cash flow would beat expectations in the near-term and he believes that the company could also become a takeover target. The analyst started coverage of Fortinet (FTNT) with a Neutral rating. PRICE ACTION: In early afternoon trading, Palo Alto climbed 3% to $78.36, FireEye rose 3.5% to $34.99, Proofpoint climbed 3.6% to $34.46, and Fortinet rose 1% to $24.24.
11:45 EDTJCIJohnson Controls July volatility elevated into Q2 and outlook
Johnson Controls July call option implied volatility is at 48, October is at 23; compared to its 26-week average of 23, suggesting large near term price movement into the expected release of Q3 results on July 18.
11:23 EDTRHHBYRoche Alzheimer drug shows mixed results in trial, NYT says
Subscribe for More Information
10:24 EDTFTNTHigh option volume stocks:
High option volume stocks: AMSC FTNT LYG TSEM FOXA HCA BKE XON LCI ASML
10:00 EDTFTNTOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: American Airlines (AAL) initiated with an Overweight at Atlantic Equities... Apple (AAPL) initiated with a Buy at Citigroup... Basic Energy (BAS) initiated with a Neutral at RW Baird... Brookdale Senior Living (BKD) initiated with a Buy at Goldman... CA Technologies (CA) initiated with a Market Perform at FBR Capital... Dresser-Rand (DRC) initiated with a Neutral at RW Baird... Fortinet (FTNT) initiated with a Neutral at Goldman... Frank's International (FI) initiated with a Hold at Jefferies... Home Bancorp (HBCP) initiated with an Outperform at Fig Partners... Key Energy (KEG) initiated with an Outperform at RW Baird... McDermott (MDR) initiated with a Neutral at Tigress Financial... ORBCOMM (ORBC) initiated with a Neutral at Macquarie... Oil States (OIS) initiated with an Outperform at RW Baird... PBF Energy (PBF) initiated with an Equal Weight at Barclays... Palo Alto (PANW) assumed with a Conviction Buy at Goldman... Proofpoint (PFPT) initiated with a Buy at Goldman... Qlik Technologies (QLIK) initiated with a Market Perform at FBR Capital... Radius Health (RDUS) initiated with a Buy at Canaccord... Seventy Seven Energy (SSE) initiated with a Hold at Jefferies... Superior Energy (SPN) initiated with an Outperform at RW Baird... Tandem Diabetes (TNDM) initiated with an Outperform at William Blair... Trecora Resources (TREC) initiated with a Buy at B. Riley... Ultragenyx (RARE) initiated with an Outperform at RW Baird... United Natural Foods (UNFI) initiated with an Outperform at Oppenheimer... Viper Energy (VNOM) initiated with a Market Perform at Northland... Whiting Petroleum (WLL) initiated with a Buy at Tigress Financial.
06:27 EDTBPBP retirement-plan case reintroduced by U.S. court, Reuters says
The 5th U.S. Circuit Court of Appeals in New Orleans brought back a case in which participants in four BP worker retirement savings plans alleged they were tricked into purchasing and holding BP stock before and after the 2010 Deepwater Horizon disaster, according to Reuters, citing comments from BP spokesman Geoff Morrell. Reference Link
06:26 EDTRHHBYBristol-Myers lung cancer trials being underestimated, says Citigroup
After building a statistical model of Bristol-Myers' two critical registration trials for Opdivo in lung cancer, Citigroup believes the market is "materially" underestimating both Phase III trials. Citi says potential Opdivo FDA approval in 2015 in lung cancer would give Bristol-Myers an up to two year lead time versus Merck (MRK) and Roche (RHHBY). The firm estimates 2023 Opdivo revenue at $7B and reiterates a Buy rating on Bristol with a $60 price target.
05:47 EDTFTNTFortinet initiated with a Neutral at Goldman
Subscribe for More Information
July 15, 2014
17:26 EDTJCIJohnson Controls awarded $450M government contract
Subscribe for More Information
12:31 EDTCOHMichael Kors sinks after analysts issue bearish notes
Subscribe for More Information
10:00 EDTDOOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:53 EDTFFIVF5 Networks poised to report strong Q2 results, says Pacific Crest
Subscribe for More Information
07:51 EDTURBNUrban Outfitters weakness a buying opportunity, says Canaccord
Subscribe for More Information
07:46 EDTBPJacobs receives project services contract from BP
Jacobs (JEC) announced that it was awarded a contract with BP (BP) to provide engineering, design and procurement services for the Coker Heater Replacement Project at its Cherry Point Refinery in Blaine, Washington. Company officials did not disclose the contract value.
06:41 EDTDODiamond Offshore upgraded to Market Perform from Underperform at BMO Capital
Subscribe for More Information
06:02 EDTARMHSamsung, Nest, ARM team up for Thread wireless networking protocol
Subscribe for More Information
05:37 EDTRHHBYGenentech Avastin granted priority review by FDA
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use